TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+0.35%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$193M
AUM Growth
+$193M
(-11%)
Cap. Flow
-$1.67M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
99.96%
Holding
13
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$9.89M |
| 2 |
Phio Pharmaceuticals
PHIO
|
$100K |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$8.6M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$3.07M |
Sector Composition
| 1 | Healthcare | 42.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLXP
1
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $46.9M | 24.29% | 300,000 | – | – |
|
2
Heron Therapeutics
HRTX
$207M
| $41M | 21.23% | 4,919,625 | – | – |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $18.4M | 9.52% | 1,911,462 +1,029,555 | +117% | +$9.89M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $13.2M | 6.82% | 182,300 | – | – |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.05M | 2.62% | 288,432 | – | – |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.68M | 1.91% | 300,000 -700,000 | -70% | -$8.6M |
|
|
7
Phio Pharmaceuticals
PHIO
$11.3M
| $100K | 0.05% | +50,219 | New | +$100K |
|
|
DNDN
8
DELISTED
DENDREON CORPORATION
DNDN
| $80K | 0.04% | 55,548 | – | – |
|
|
ECYT
9
DELISTED
Endocyte, Inc. Common Stock
ECYT
| – | – | -465,763 | Closed | -$3.07M |
|
|
AMBI
10
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $0 | ﹤0.01% | 46 | – | – |
|